DRAVET SYNDROME

Clinical trials for DRAVET SYNDROME explained in plain language.

Never miss a new study

Get alerted when new DRAVET SYNDROME trials appear

Sign up with your email to follow new studies for DRAVET SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 11 Completed 4 Terminated 2

Could a seizure drug also prevent sudden death in dravet syndrome?

Disease control Not yet recruiting

This study tests whether the drug Fintepla (fenfluramine) can improve how the brain and lungs respond to carbon dioxide in people with Dravet syndrome, a severe epilepsy. Poor responses to CO2 may increase the risk of sudden unexpected death in epilepsy (SUDEP). Twenty-five parti…

Matched conditions: DRAVET SYNDROME

Phase: PHASE4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

DRAVET SYNDROME

Get alerted when new DRAVET SYNDROME trials appear

Could a seizure drug also prevent sudden death in dravet syndrome?